Cell Press Multi-Journal Submission: How It Actually Works

You pick between 2 and 5 Cell Press journals at submission and put them in order of preference. One handling editor is assigned as your single point of contact, the same editor for the whole process, rather than a new editor at each journal in a sequential resubmission. That editor gives the manuscript an in-depth assessment and coordinates with editors from your other selected journals to decide where, if anywhere, it fits.

Because every journal on your list already knows the manuscript is under simultaneous consideration, MJS sidesteps the ethical problem a real dual submission would create: nothing here is happening behind any editor's back.

The traditional path is sequential: submit to journal A, wait for a decision, and if it's declined, start over at journal B with a fresh submission and a fresh editor who knows nothing about the paper's history. Cell Press's own reporting puts MJS papers at roughly 42 days faster to acceptance on average than that sequential path, largely because the handling editor already has the full picture and doesn't need a second cold read to place the paper at journal B if journal A isn't the fit.

Think twice if: you're choosing MJS purely to "maximize your odds" by listing five journals you'd never actually target on their own. The handling editor is evaluating fit across your list, not running a lottery; a mismatched fifth choice doesn't meaningfully raise your odds and can read as a weaker signal about how well you understand your own paper's scope.

Cell Press describes MJS as covering roughly 30 participating life, medical, and physical science titles, expanded in 2024 to add select physical science journals alongside its original life and medical science coverage. Two named journals sit outside the program: Heliyon and STAR Protocols. The exact participating roster has already changed once, so confirm the current list and count on Cell Press's own Multi-Journal Submission page before you build your ranked list around it, rather than relying on this page's snapshot or an older secondary source.

If reviewers have already evaluated your manuscript and the handling editor decides a different journal on your list is a better fit, the reviewer reports transfer with the manuscript, and the new journal's editors reuse that feedback to speed up their own decision rather than starting review from zero. Each journal still runs its own independent evaluation of that feedback, but you're not paying the full review-cycle cost twice for the same manuscript, which is a meaningful part of where MJS's speed advantage over a manual resubmission actually comes from.

The underlying manuscript file, your data, methods, figures, and results, does not change across the journals on your ranked list. The handling editor is reading the same evidence package regardless of which journal on your list eventually reviews it.

What does need to work across every journal you rank is the framing: the introduction's claim of significance and the cover letter's pitch have to make sense at your first choice and your third choice simultaneously, because the same editor reads both against the same manuscript. A cover letter written narrowly for one flagship journal's specific concerns can undersell the paper's fit at a more specialized journal further down your list. Write the significance case broadly enough to hold across your full ranked set, and let the ranking itself, not the pitch, communicate your priority.

If your top choice is Cell itself, our Cell Press submission guidelines covers what the flagship journal specifically screens for, mechanistic completeness and field-level consequence, which is a materially different bar than most of the rest of the portfolio.